2006
DOI: 10.1007/s11095-005-8812-5
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Human Liver Slices and Reporter Gene Assays as Systems for Predicting the Cytochrome P450 Induction Potential of Drugs in Vivo in Humans

Abstract: Liver slices are a valuable model to study the regulation of a larger number of enzymes by single compounds. The PXR reporter gene assay could be used as a reliable screening method to predict CYP3A induction in vivo.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
39
1
4

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 63 publications
(46 citation statements)
references
References 55 publications
2
39
1
4
Order By: Relevance
“…Results from PXR reporter gene assays were recently successfully used to classify clinically used drugs as CYP3A inducers or noninducers (Persson et al, 2006;Sinz et al, 2006). However, because induction of P450 enzymes by drug molecules does not only depend on a single transcription factor but is mediated by a combination of several transcription factors in the cell, a human hepatocyte-like cell line would be a superior in vitro model for evaluation of P450 induction.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Results from PXR reporter gene assays were recently successfully used to classify clinically used drugs as CYP3A inducers or noninducers (Persson et al, 2006;Sinz et al, 2006). However, because induction of P450 enzymes by drug molecules does not only depend on a single transcription factor but is mediated by a combination of several transcription factors in the cell, a human hepatocyte-like cell line would be a superior in vitro model for evaluation of P450 induction.…”
mentioning
confidence: 99%
“…Real-time PCR for human P450 mRNA levels was performed using a 7500 Sequence Detector (Applied Biosystems, Foster City, CA) and manufacturer-designed Assay on Demand for CYP1A1, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, and glyceraldehyde-3-phosphate dehydrogenase. For human acidic ribosomal phosphoprotein (huPO), gene-specific double fluorescent labeled probes were used as reported previously (Persson et al, 2006). The reaction mixture (25 l/well) contained 30 ng of cDNA, 1ϫTaqman Universal Master Mix, optimized concentrations of primers and probes (huPO), or 1.25 l of Assay on Demand and RNase free water.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Изолированные срезы печени и выделенные из них микросомы использовались для исследования индукции экспрессии генов цитохромов Р450 при инкубации с лекарственными препаратами: карбамазепином, клотримазолом, дексаметазоном, гиперфолином, ловастатином, омепразолом, фенобарбиталом, фенитоином, примакином, рифампицином, TCDD, троглитазоном. После введения коктейля маркерных субстратов (фенацетин, диклофенак, мидазолам) проводился LC/MS анализ активности по регистрации метаболитов: парацетамол (CYP1A2), 4-OH-диклофенак (CYP2C9), и 1-OH-мидазолам (CYP3A) [111].…”
Section: цитохромы р450unclassified
“…Такой подход получил название "cocktail" или "N-in-1 assay" [103,111,112]. Исследовались микросомы печени человека и бакулосомы с экспрессированными человеческими цитохромами CYP1A2, 2A6, 2B6, 2C8, 2С9, 2C19, 2D6, 2E1, 3A4 3A5.…”
Section: цитохромы р450unclassified